November 24, 2021
Video
Clinical pearls regarding molecular testing and treatment selection in metastatic cholangiocarcinoma.
November 24, 2021
Video
Implications for treating select patients with metastatic cholangiocarcinoma with ivosidenib as second-line therapy.
November 24, 2021
Video
Insight pertaining to the use of infigratinib and pemigatinib, FGFR inhibitors, as second-line therapy for metastatic cholangiocarcinoma.
November 24, 2021
Video
An overview of the standard of care for patients with metastatic cholangiocarcinoma, and the significance of conducting clinical trials that increase the number and types of therapies available to patients with fewer adverse events and better results.
November 24, 2021
Video
Recommendations for conducting molecular testing and biopsies to learn more about patients who present with metastatic cholangiocarcinoma.
November 24, 2021
Video
Dr Afsaneh Barzi explains why screening measures for cholangiocarcinoma are so important to patient outcomes.